Andrew J. Grottick

Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine2C Agonist: in Vitro and in Vivo Pharmacological Characterization

William Thomsen, Andrew J. Grottick, Frederique Menzaghi et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 402 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task

Andrew J. Grottick, Guy A. Higgins · Behavioural Brain Research · 2000 · 239 citations

Medicine, Neuroscience, Pharmacology +12

Studies to Investigate the Role of 5-HT2C Receptors on Cocaine- and Food-Maintained Behavior

Andrew J. Grottick, Paul Fletcher, Guy A. Higgins · Journal of Pharmacology and Experimental Therapeutics · 2000 · 212 citations

Medicine, Neurobiology, Pharmacology +17

Discovery and Structure−Activity Relationship of (1<i>R</i>)-8-Chloro-2,3,4,5-tetrahydro-1-methyl-1<i>H</i>-3-benzazepine (Lorcaserin), a Selective Serotonin 5-HT_2C Receptor Agonist for the Treatment of Obesity

Brian M. Smith, Jeffrey M. Smith, James H. Tsai et al. · Journal of Medicinal Chemistry · 2007 · 202 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine.

Andrew J. Grottick, Gerhard Trube, W. Corrigall et al. · PubMed · 2000 · 142 citations

Medicine, Neuroscience, Pharmacology +17